Embolization Particle Market: By Product Type (Radioembolization Spheres, Drug Eluting Beads, Microspheres, PVA Particles & Gelfoam Particles, Others), By Application (Oncology, Peripheral Vascular Disease, Urology, Neurology, Others), By End User (Ambulatory Centers, Hospitals, Clinics) And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
[170+ Pages Research Report] Embolization Particle Market to surpass USD 8 billion by 2032 from USD 2.13 billion in 2021 at a CAGR of 12.7% throughout the forecast period 2022-32.
Embolization is a minimal invasive procedure where an embolus is injected to cease bleeding or to terminate blood supply to tumor for it to shrink in order to remove. Embolization is helpful in radiology procedures, to treat hemorrhages, several cancerous tumors & management of malignant. For this process, interventional radiologist uses image guidance to insert the catheter into blood vessel to terminate blood supply. Embolization is an alternative for tumors patients where surgery can’t be performed. It can be used for tumors that are generally greater than 5 cm thickness & cannot be separated by ablation. This procedure involves the initiation of emboli for occluding the blood vessels selectively.
Embolization Particle market is expected to project a CAGR of 12.7% during the forecast period
Embolization Particle market is expected to exceed beyond USD 8.0 billion by 2032 from USD 2.13 billion in 2021, growing at a CAGR of 12.7% during the forecast period, 2022-2032. Embolization particles are vital ingredients used to treat malignancies and the rising prevalence of cancer has aided in the growth of the embolization particle market. The increasing burden of cancer in several countries is expected to boost the growth of the market. The increasing expenditure of government to improve the pharmaceutical Research & Development is estimated to boost the growth of the Embolization Particle market.
Peripheral Vascular Disease segment is expected to grow with a higher CAGR during 2022-32
Embolization Particle market is classified based on Application into Oncology, Peripheral Vascular Disease, Urology, Neurology, Others. Peripheral Vascular Disease segment dominated the market in 2021 and is also expected to dominate in the forecast period owing to the rising prevalence of cancers and strong expansion of the oncology sector which is expected to drive the market growth in the forecast period. Embolization Particles are the key products used in malignancies treatment and the increasing awareness about embolization procedures is expected to boost the growth of Embolization Particle market.
Radioembolization Spheres segment is expected to grow with a higher CAGR during 2022-32
Embolization Particle market is classified based on the Product Type into Radioembolization Spheres, Drug Eluting Beads, Microspheres, PVA Particles & Gelfoam Particles, Others. Radioembolization Spheres segment is expected to dominate the Embolization Particle market as the embolization Particles are used in the treatment of cancer which are of major importance in the growth of the market.
Rising Occurrence of Cancer is Expected to Boost the Growth of the Market
The occurrence of cancers like prostrate, liver, bowel, breast, lung cancers has increased and the necessity of embolization particles has raised which created a growth opportunity for the market. The people being affected with various types of cancers is increasing and the proliferation of cancerous cells is rising which is creating demand for the growth of the Embolization Particle market.
Increasing Advancements in Technology is Expected to Drive the Market Growth
The key market players are focusing on implementing advancements in technology to innovate various novel products which has a scope of improvement and increased efficiency that will assist in the growth of the market. New therapies are emerging as an alternative option to the traditional therapies and are expected to boost the growth of the Embolization Particle market.
Stringent Regulations for Approval of Embolization Particles is Expected to Restrain the Market Growth
The Embolization Particle Market expansion would be hindered due to the presence of a smaller number of labs related to interventional neuroradiologists and neuroradiology (INR). The stringent regulations for the approval of embolization particle may also restrain the growth of the global embolization particle market. The deficiency of presence of skilled professionals may hamper the growth of the global embolization particle market.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Embolization Particle market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the market with the largest share in 2021 owing to the large expansion of healthcare system, the presence of strong economic condition in the region and rising focus on modernizing of the technology by research institutions. The Asia Pacific market is expected to dominate the Embolization Particle market in the forecast period owing to the availability of skilled healthcare professionals, rising patient population, increasing medical tourism and increasing government initiatives for enhancing healthcare facilities which is expected to boost the growth of the market in this region.